Boobalan Pachaiyappan's Stock Coverage
| TRDAEntrada Therapeutics Inc | Nov 05, 2026 | BUY | Reiterated | $10.00 | 23Ratings | -12.55% | ||
| PMNProMIS Neurosciences | Nov 02, 2026 | BUY | Assigned | $15.00 | 4Ratings | -46.30% | ||
| PYPDPolyPid | Oct 29, 2026 | BUY | Reiterated | $8.00 | 22Ratings | +22.65% | ||
| RNAAtrium Therapeutics, Inc. | Oct 22, 2026 | BUY | Initiated | $15.00 | 1Ratings | +6.80% | ||
| COYACoya Therapeutics, Inc. | Oct 15, 2026 | BUY | Reiterated | $12.00 | 4Ratings | -35.00% | ||
| NRSNNeurosense Therapeutics Ltd. | Oct 13, 2026 | HOLD | Downgraded | $3.50 | 7Ratings | -78.30% | ||
| CRVOCervoMed | Oct 13, 2026 | BUY | Reiterated | $7.00 | 23Ratings | -30.79% | ||
| CAPRCapricor Therapeutics | Oct 06, 2026 | HOLD | Reiterated | $7.00 | 19Ratings | +29.10% | ||
| LBRXLB Pharmaceuticals, Inc. | Oct 05, 2026 | HOLD | Downgraded | $35.00 | 6Ratings | +41.67% | ||
| NWRNNewron Pharmaceuticals SpA | Oct 05, 2026 | BUY | Assigned | CHF19.00 | 1Ratings | 0.00% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Boobalan Pachaiyappan activity FAQ
What is the performance of Boobalan Pachaiyappan's recommendations?
The percentage of profitable recommendations made by Boobalan Pachaiyappan is 34.83%, and the average return per transaction is -14.90%.
What stocks does Boobalan Pachaiyappan cover?
What was Boobalan Pachaiyappan's most profitable rating?
Boobalan Pachaiyappan’s most profitable rating was a buy on Capricor Therapeutics stock on Jun 20, 2025. The return on the trade was 243.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here